Nutra Pharma's Rik Deitsch Interviewed by The Life Sciences Report
SAN FRANCISCO, CA--(Marketwired - October 22, 2015) - Nutra Pharma Corp. (OTC PINK: NPHC) is pursuing a strategy of over-the-counter sales as it advances a therapeutic pipeline based on cobra toxin. In this interview with The Life Sciences Report, CEO Rik …